The comparison of nasal irrigation outcome between 3% NaCl and 0.9% NaCl in adults majority with intermittent allergic rhinitis: A randomized double-blind study

被引:2
|
作者
Yata, Kedsaraporn [1 ]
Srivanitchapoom, Chonticha [1 ]
机构
[1] Phayao Hosp, Otolaryngol Unit, 269 Moo 11, Muang Phayao, Phayao, Thailand
关键词
nasal irrigation; 3% NaCl; 0.9% NaCl; hypertonic saline; allergic rhinitis; HYPERTONIC SALINE; MUCOCILIARY CLEARANCE; CHILDREN; ASTHMA; CONGESTION; IMPACT;
D O I
10.12932/AP-140520-0844
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Management of allergic rhinitis with oral antihistamine and steroid nasal spray are the standard treatment which is recommended by Allergic Rhinitis and its Impact on Asthma guidelines. In addition, nasal irrigation as an adjuvant therapy also provides a satisfactory result. Objective: To compare the treatment outcome in adults majority with intermittent allergic rhinitis who receive different concentrations of nasal irrigation. Methods: The prospective randomized double-blind study was performed in 80 patients. All patients were prescribed oral antihistamine and nasal irrigated solution between 3% NaCl and 0.9% NaCl. Nasal congestion and rhinorrhea were evaluated at baseline, first and second weeks after treatment. Assessments were measured by nasal congestion visual analog scale rhinorrhea visual analog scale, inferior turbinate size, and peak nasal expiratory flow rate (PNEFR). A p value of < 0.05 was considered statistically significant. Results: There were 40 patients in each group of the study. Patients reported satisfactory experience after using saline irrigation at first and second weeks in both solutions (p value < 0.001). However, when compared between groups, no significant differences for all parameters were reported. PNEFR showed good results after the first week of 3% NaCl irrigation (p value = 0.001), while 0.9% NaCl had good results after the second week (p value < 0.001). Conclusion: Both add-on treatments have a significant improvement of all 4 parameters assessed in the study: nasal congestion, rhinorrhca, inferior turbinate size and PNEFR. Of note, 3% NaCl but not 0.9 NaCl had improved the PNEFR earlier from 1 week of the treatment.
引用
收藏
页码:9 / 14
页数:6
相关论文
共 50 条
  • [31] Efficacy and Safety of Fluticasone Furoate Nasal Spray in Japanese Children with Perennial Allergic Rhinitis: A Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial
    Okubo, Kimihiro
    Okamasa, Arisa
    Honma, Gosuke
    Komatsubara, Masaki
    ALLERGOLOGY INTERNATIONAL, 2014, 63 (04) : 543 - 551
  • [32] Research on allergic rhinitis improvement in asthmatic children after dust mite exposure reduction: a randomized, double-blind, cross-placebo study protocol
    Chen, Ming
    Wu, YuFen
    Yuan, Shuhua
    Chen, Jiande
    Li, Luanluan
    Wu, Jinhong
    Zhang, Jing
    Yin, Yong
    TRIALS, 2020, 21 (01)
  • [33] Research on allergic rhinitis improvement in asthmatic children after dust mite exposure reduction: a randomized, double-blind, cross-placebo study protocol
    Ming Chen
    YuFen Wu
    Shuhua Yuan
    Jiande Chen
    Luanluan Li
    Jinhong Wu
    Jing Zhang
    Yong Yin
    Trials, 21
  • [34] A topical microemulsion for the prevention of allergic rhinitis symptoms: results of a randomized, controlled, double-blind, parallel group, multicentre, multinational clinical trial (Nares study)
    Ojeda, Pedro
    Pique, Nuria
    Alonso, Alicia
    Delgado, Julio
    Feo, Francisco
    Manuel Igea, Juan
    Navarro, Ana
    Maria Olaguibel, Jose
    Subiza, Javier
    Nieto, Carles
    Andersson, Morgan
    ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2013, 9
  • [35] Amphotericin B irrigation for the treatment of chronic rhinosinusitis without nasal polyps: A randomized, placebo-controlled, double-blind study
    Liang, Kai-Li
    Su, Mao-Chang
    Shiao, Jiun-Yi
    Tseng, Hung-Cheng
    Hsin, Chung-Han
    Lin, Jen-Fu
    Jiang, Rong-San
    AMERICAN JOURNAL OF RHINOLOGY, 2008, 22 (01): : 52 - 58
  • [36] Immunogenic yeast-based fermentation product reduces allergic rhinitis-induced nasal congestion: a randomized, double-blind, placebo-controlled trial
    Mark A. Moyad
    Larry E. Robinson
    Julie M. Kittelsrud
    Stuart G. Reeves
    Susan E. Weaver
    Aireen I. Guzman
    Mark E. Bubak
    Advances in Therapy, 2009, 26 : 795 - 804
  • [37] Efficacy of mometasone furoate nasal spray in the treatment of allergic rhinitis. Meta-analysis of randomized, double-blind, placebo-controlled, clinical trials
    Penagos, M.
    Compalati, E.
    Tarantini, F.
    Baena-Cagnani, C. E.
    Passalacqua, G.
    Canonica, G. W.
    ALLERGY, 2008, 63 (10) : 1280 - 1291
  • [38] The efficacy and safety of Yupingfeng Powder with variation in the treatment of allergic rhinitis: Study protocol for a randomized, double-blind, placebo-controlled trial
    Cheong, Pui Kuan
    Ho, Tin Muk
    Chan, Kam Leung
    Lo, Cho Wing
    Leung, Sin Bond
    Hon, Kam Lun
    Leung, Ka Chun
    Siu, Tony Hon Chung
    Song, Tian-He
    Zhang, Hongwei
    Ching, Jessica Yuet Ling
    Chow, Tak Yee
    Sum, Chi Him
    Chia, Chon Pin
    Lin, Zhi-Xiu
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [39] Safety and Tolerability of Fluticasone Furoate Nasal Spray Once Daily in Paediatric Patients Aged 6-11 Years with Allergic Rhinitis Subanalysis of Three Randomized, Double-Blind, Placebo-Controlled, Multicentre Studies
    Meltzer, Eli O.
    Tripathy, Ita
    Maspero, Jorge F.
    Wu, Wei
    Philpot, Ed
    CLINICAL DRUG INVESTIGATION, 2009, 29 (02) : 79 - 86
  • [40] Preferences of adult patients with allergic rhinitis for the sensory attributes of fluticasone furoate versus fluticasone propionate nasal sprays: A randomized, multicenter, double-blind, single-dose, crossover study
    Meltzer, Eli O.
    Stahlman, Jon E.
    Leflein, Jeffrey
    Meltzer, Steven
    Lim, Junghee
    Dalal, Anand A.
    Prillaman, Barbara A.
    Philpot, Edward E.
    CLINICAL THERAPEUTICS, 2008, 30 (02) : 271 - 279